XML 63 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1

Components of Expenses (Tables)

12 Months Ended

Dec. 31, 2023

Analysis of income and expense [abstract]

Other expenses and adjustments

			2023						2022						2021
Research and development expenses
Clinical trial expenses			$	3,675					$	4,970					$	3,205
Manufacturing & related process development expenses			5,789						2,148						1,547
Intellectual property expenses			397						544						618
Translational science expenses			—						264						673
Personnel-related expenses			6,324						6,023						4,754
Share-based compensation expense			1,305						1,371						2,087
Other expenses			219						112						36
			$	17,709					$	15,432					$	12,920

			2023						2022						2021
General and administrative expenses
Public company-related expenses			$	11,278					$	6,790					$	8,161
Office expenses			3,789						3,303						2,963
Share-based compensation expense			612						1,007						1,739
Depreciation - property and equipment			81						93						130
Depreciation - right-of-use assets			322						299						322
			$	16,082					$	11,492					$	13,315

X

- References

No definition available.

+ Details

Name:	ifrs-full_AnalysisOfIncomeAndExpenseAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Other Expenses And Adjustments [Table Text Block]

+ References

No definition available.

+ Details

Name:	oncyf_OtherExpensesAndAdjustmentsTableTextBlock
Namespace Prefix:	oncyf_
Data Type:	dtr-types1:textBlockItemType
Balance Type:	na
Period Type:	duration